These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1069859)

  • 1. Ssytemic effects of intravenous polyriboinosinic-polyribocytidylic acid in man.
    Cornell CJ; Smith KA; Cornwell GG; Burke GP; McIntyre OR
    J Natl Cancer Inst; 1976 Dec; 57(6):1211-6. PubMed ID: 1069859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors.
    Robinson RA; DeVita VT; Levy HB; Baron S; Hubbard SP; Levine AS
    J Natl Cancer Inst; 1976 Sep; 57(3):599-602. PubMed ID: 978771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.
    Levine AS; Sivulich M; Wiernik PH; Levy HB
    Cancer Res; 1979 May; 39(5):1645-50. PubMed ID: 371793
    [No Abstract]   [Full Text] [Related]  

  • 4. The fever induced by polyriboinosinic:polyribocytidylic acid is not related to interferon synthesis in the rabbit's hypothalamus.
    Won SJ; Lin MT; Ko YH; Chuang J
    J Interferon Res; 1991 Jun; 11(3):165-9. PubMed ID: 1717613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.
    Gatmaitan BG; Legaspi RC; Levy HB; Lerner AM
    Antimicrob Agents Chemother; 1980 Jan; 17(1):49-54. PubMed ID: 7352750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly (I)-poly (C)], in children.
    Guggenheim MA; Baron S
    J Infect Dis; 1977 Jul; 136(1):50-8. PubMed ID: 328786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
    Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
    Cancer Res; 1985 Nov; 45(11 Pt 2):5904-9. PubMed ID: 2414002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Eastern Cooperative Oncology Group phase I-II pilot study of polyriboinosinic-polyribocytidylic acid poly-L-lysine complex in patients with metastatic malignant melanoma.
    Hawkins MJ; Levin M; Borden EC
    J Biol Response Mod; 1985 Dec; 4(6):664-8. PubMed ID: 2418164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II trials of poly IC stabilized with poly-L-lysine.
    Levine AS; Levy HB
    Cancer Treat Rep; 1978 Nov; 62(11):1907-12. PubMed ID: 728910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.
    Champney KJ; Levine DP; Levy HB; Lerner AM
    Infect Immun; 1979 Sep; 25(3):831-7. PubMed ID: 500189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components.
    Gatmaitan BG; Levy HB; Lerner AM
    Antimicrob Agents Chemother; 1980 Sep; 18(3):409-15. PubMed ID: 6158914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon induction in cancer: with some observations on the clinical effects of poly 1:C.
    Young CW
    Med Clin North Am; 1971 May; 55(3):721-8. PubMed ID: 4932880
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of mouse interferon and polyriboinosinic acid-polyribocytidylic acid on L-cell tumor growth in nude mice.
    Clercq ED
    Cancer Res; 1977 May; 37(5):1502-6. PubMed ID: 856466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex on Herpesvirus hominis infections in mice.
    Olsen GA; Kern ER; Overall JC
    J Infect Dis; 1978 Apr; 137(4):428-36. PubMed ID: 206632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic metabolic alterations associated with repeated injections of a modified polyriboinosinic-polyribocytidylic acid complex.
    Powanda MC; Sammons ML; Stephen EL
    Antimicrob Agents Chemother; 1977 Nov; 12(5):602-5. PubMed ID: 921256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
    Sammons ML; Stephen EL; Levy HB; Baron S; Hilmas DE
    Antimicrob Agents Chemother; 1977 Jan; 11(1):80-3. PubMed ID: 402107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile effects of polyriboinosinic acid: polyribocytidylic acid and interferon: relationship to somatostatin in rat hypothalamus.
    Chuang J; Lin MT; Chan SA; Won SJ
    Pflugers Arch; 1990 Feb; 415(5):606-10. PubMed ID: 1691481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of experimental rabies with the polyriboinosinic-polyribocytidylic acid complex.
    Fenje P; Postic B
    J Infect Dis; 1971 Apr; 123(4):426-8. PubMed ID: 5110740
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial of poly I--poly C as an immunity adjuvant and an immunorestoration agent.
    Simmler MC; Bruley-Rosset M; Belpomme D; Schwarzenberg L
    Eur J Cancer (1965); 1977; 13(4-5):463-7. PubMed ID: 326559
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of polynucleotides on solid tumor produced in mice by Ehrlich ascites cancer cells.
    Nagano Y; Takano S
    J Interferon Res; 1982; 2(1):103-5. PubMed ID: 6180096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.